Real-time enrollment status for this recurrent world health organization (who) grade ii glioma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:50 AM UTC
| NCT Number | NCT04540107 |
| Recruiting Status | Recruiting |
| Condition | Recurrent World Health Organization (WHO) Grade II Glioma |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Susan Chang |
| Last Updated on CT.gov | April 29, 2026 (Apr 29, 2026) |
As of July 13, 2026: Clinical trial NCT04540107 is currently recruiting participants. This clinical trial study for recurrent world health organization (who) grade ii glioma is actively seeking new participants at 1 location across the United States. The study is sponsored by Susan Chang. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04540107 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04540107 was last updated Apr 29, 2026 (April 29, 2026). HelloStudys verifies this status automatically.